42 pharmaceutical, biopharmaceutical, and health care research and development services, namely, basic and applied research and product development of pharmaceuticals and biologic agents for the prevention and treatment of human diseases in the fields of autoimmunity, inflammation, oncology, fibrosis, and neurodegeneration